NEW YORK, December 28, 2015 /PRNewswire/ --
The global neurostimulation devices market was valued at $5,027.7 million in 2014, and it is expected to grow with a CAGR of 12.7% during the period 2015 - 2020. The global market is increasing, due to growing geriatric population and increasing incidence of neurological disorders. In addition, the growing awareness about mental diseases and their treatment, increasing research and development investments, and growing demand of minimally invasive treatments is encouraging the growth of the global neurostimulation devices market.
(Logo: http://photos.prnewswire.com/prnh/20150727/756778 )
Based on type of devices, the implantable/internal devices segment is expected to witness the fastest growth during the forecast period. Among the various applications, the pain management segment accounted for the largest share in the global market in 2014; and the segment is expected to witness the fastest growth, with 13.5% CAGR during the 2015 - 2020.
Explore Report Description with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/neurostimulation-devices-market
The information and data in the publication "Global Neurostimulation devices Market Size, Share, Development, Growth and Demand Forecast to 2020" represent the research and analysis of data from various primary and secondary sources. The bottom-up approach has been used to calculate the size of the global Neurostimulation devices market by type of devices and application. The market numbers for countries are obtained through top-down approach. P&S Market Research analysts and consultants interacted with the authorities from leading companies of the concerned domain, to substantiate every value of data presented in this report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online and offline research.
The aging population is playing a key role in the growth of the global neurostimulation devices market. The elderly people are more susceptible to chronic pain and neurological disorders, such as Alzheimer's disease, epilepsy, and Parkinson's disease, as compared to adults. According to the National Institutes of Health (NIH), an organization that conducts and supports medical research activities across the world, about 75% to 85% of older people in elderly care facilities suffer from chronic pain, which is boosting the demand of Neurostimulation devices.
Ask For Sample Pages: https://www.psmarketresearch.com/market-analysis/neurostimulation-devices-market/report-sample
The awareness about mental diseases is increasing across the world, owing to increased investments and initiatives taken by private and public health institutions for raising awareness about mental diseases and available treatments in the market. The R&D investments in the development of novel and innovative neurostimulation devices are growing, owing to increased demand for effective neurological devices for the treatment of neurological diseases. Moreover, the currently available devices require surgical implantation and replacement surgeries after every few years. The technologically advanced devices facilitate non-invasive procedures for the safe and effective treatment of drug-resistant neurological disorders, which is acting as a major growth driver for the global neurostimulation devices market.
However, the availability of alternative treatments such as drug therapies, and various surgeries such as pallidotomy and thalamotomy for treating Parkinson's disease; lobe resection, lesionectomy, and corpus callosotomy for treating epilepsy, acts as major restraints for the growth of the global market of neurostimulation devices. In addition, the high cost as well as side effects of neurostimulation devices is further restraining the growth of the market. The Asian market is expected to witness the fastest growth, with a CAGR of 13.8% during the period 2015 - 2020.
The key companies operating in the global neurostimulation devices market include Medtronic PLC, St. Jude Medical Inc., Cyberonics Inc., Boston Scientific Corporation, Cochlear Ltd., MED-EL, NeuroPace Inc., NeuroSigma Inc., NDI Medical LLC, and Neuronetics Inc.
Browse Related Reports @ https://www.psmarketresearch.com/industry-report/medical-devices
GLOBAL NEUROSTIMULATION DEVICES MARKET SEGMENTATION
By Type of Devices
By Type of Implantable/Internal Devices
By Type of External Devices
By Application
By Geography
Browse Other Latest Published Reports
Prefilled Syringes Market- https://www.psmarketresearch.com/market-analysis/prefilled-syringes-market
Self-Monitoring Blood Glucose (SMBG) Devices Market- https://www.psmarketresearch.com/market-analysis/self-monitoring-blood-glucose-market
Non-Invasive Prenatal Testing (NIPT) Market- https://www.psmarketresearch.com/market-analysis/non-invasive-prenatal-testing-market
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we're keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
Ms Somya
Manager - Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Share this article